Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) announced it will release its second quarter 2022 financial results on August 2, 2022, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) announced it will release its second quarter 2022 financial results on August 2, 2022, before market open. A conference call will follow at 5:30 a.m. PT to discuss results, business developments, and future outlook. Nautilus is focused on developing a single-molecule protein analysis platform aimed at advancing proteomics for improved health and medicine.
Positive
- Upcoming financial results expected to provide insights into company performance.
- Management conference call suggests transparency and engagement with investors.
Negative
- None.
Details
News Market Reaction – NAUT
The recorded move for NAUT in the trading session of this news was +1.77%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 2nd, 2022.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media contact
Thermal for Nautilus Biotechnology
Kaustuva Das
press@nautilus.bio
Investor Contact
investorRelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.